SCHEMBL7076085

SCHEMBL7076085

CCCCC1(CC)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8380775 1.00
SCHEMBL11851085 0.89 GAA (0.38)
SCHEMBL1694487 0.76
SCHEMBL9419612 0.75 GAA (0.39)
SCHEMBL5585816 0.75 GAA (0.31)
SCHEMBL1117725 0.73 GAA (0.30)
SCHEMBL21078166 0.73 GAA (0.30)
SCHEMBL23740134 0.72 TSHR (0.35)
SCHEMBL17099624 0.71
SCHEMBL5585356 0.69 GAA (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1145619-C 1-4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof ���ĵ�˹ҩ��¹����޹�˾ 2004-04-14 CN disclosed
EP-1169313-B1 1,4-BENZOTHIAZEPINE-1,1-DIOXIDE DERIVATIVES SUBSTITUTED BY SUGAR RADICALS, METHODS FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THE USE THEREOF AVENTIS PHARMA GMBH (DE) 2003-06-25 EP disclosed
EP-0775126-B1 HYPOLIPIDEMIC 1,4-BENZOTHIAZEPINE-1,1-DIOXIDES WELLCOME FOUND (GB) 2002-10-30 EP disclosed
EP-0683774-B1 HYPOLIPIDAEMIC COMPOUNDS WELLCOME FOUND (GB) 2002-10-09 EP disclosed
EP-1203769-A1 Hypolipidemic 1,4-benzothiazepine derivative THE WELLCOME FOUNDATION LIMITED (GB) 2002-05-08 EP disclosed
CN-1346352-A 1, 4-benzothiazepine-1, 1-dioxide derivatives substituted by sugar radicals, method for the production thereof, medicaments containing these compounds and the use thereof AVENTIS PHARMA GMBH (DE) 2002-04-24 CN disclosed
EP-1169313-A2 1,4-BENZOTHIAZEPINE-1,1-DIOXIDE DERIVATIVES SUBSTITUTED BY SUGAR RADICALS, METHODS FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THE USE THEREOF Aventis Pharma Deutschland GmbH (DE) 2002-01-09 EP disclosed
US-6277831-B1 TREATMENT OF HYPERLIPIDEMIA, ARTERIOSCLEROSIS HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC ACTION; HIGHER EXCRETION OF BILE ACID EVEN AT A LOWER DOSAGE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-08-21 US disclosed
CN-1059673-C Hypolipidemic 1, 4-benzazepine * -1, 1-dioxides WELLCOME FOUND (GB) 2000-12-20 CN disclosed
WO-2000061568-A2 1,4-BENZOTHIAZEPINE-1,1-DIOXIDE DERIVATIVES SUBSTITUTED BY SUGAR RADICALS, METHODS FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THE USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-10-19 WO disclosed
US-5817652-A ATHEROSCLEROSIS GLAXO WELLCOME INC. (US) 1998-10-06 US disclosed
US-5723458-A 1,4-BENZOTHIAZEPINES GLAXO WELLCOME INC. (US) 1998-03-03 US disclosed
CN-1161035-A Hypolipidemic 1,4-benzothiazepine-1,1-dioxides WELLCOME FOUND (GB) 1997-10-01 CN disclosed
EP-0683773-B1 HYPOLIPIDAEMIC CONDENSED 1,4-THIAZEPINES WELLCOME FOUND (GB) 1997-09-17 EP disclosed
US-5663165-A ANTICHOLESTEROL, CARDIOVASCULAR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
EP-0683773-A1 HYPOLIPIDAEMIC CONDENSED 1,4-THIAZEPINES. WELLCOME FOUND (GB) 1995-11-29 EP disclosed
EP-0626952-A1 HYPOLIPIDAEMIC BENZOTHIAZEPINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1994-12-07 EP disclosed
WO-1994018184-A1 HYPOLIPIDAEMIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1994-08-18 WO disclosed
WO-1994018183-A1 HYPOLIPIDAEMIC CONDENSED 1,4-THIAZEPINES THE WELLCOME FOUNDATION LIMITED (GB) 1994-08-18 WO disclosed
WO-1993016055-A1 HYPOLIPIDAEMIC BENZOTHIAZEPINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-08-19 WO disclosed